PR Newswire - Harbour BioMed Secures Landmark Victory in U.S. Pa...
The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed patents protecting Harbour's groundbreaking antibody discovery platfo...
Read More

ภาษาไทย
English